Inspire Investing LLC lessened its holdings in shares of Trupanion, Inc. (NASDAQ:TRUP – Free Report) by 13.3% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 8,352 shares of the financial services provider’s stock after selling 1,277 shares during the quarter. Inspire Investing LLC’s holdings in Trupanion were worth $403,000 as of its most recent filing with the SEC.
Several other hedge funds and other institutional investors have also made changes to their positions in the business. FMR LLC grew its stake in Trupanion by 55,963.7% during the 3rd quarter. FMR LLC now owns 1,172,293 shares of the financial services provider’s stock worth $49,213,000 after purchasing an additional 1,170,202 shares in the last quarter. Renaissance Technologies LLC acquired a new position in shares of Trupanion during the second quarter worth about $4,739,000. Barclays PLC increased its stake in shares of Trupanion by 259.2% during the third quarter. Barclays PLC now owns 65,498 shares of the financial services provider’s stock worth $2,750,000 after buying an additional 47,262 shares during the period. OmniStar Financial Group Inc. purchased a new stake in shares of Trupanion during the third quarter worth approximately $535,000. Finally, Centiva Capital LP purchased a new position in Trupanion in the third quarter worth approximately $595,000.
Trupanion Stock Up 1.3 %
TRUP opened at $48.90 on Friday. The stock has a market capitalization of $2.07 billion, a P/E ratio of -152.81, a price-to-earnings-growth ratio of 8.11 and a beta of 1.61. The company has a debt-to-equity ratio of 0.40, a quick ratio of 1.66 and a current ratio of 1.66. Trupanion, Inc. has a one year low of $19.69 and a one year high of $57.90. The business’s 50-day simple moving average is $50.52 and its 200-day simple moving average is $46.10.
Wall Street Analysts Forecast Growth
A number of equities research analysts have recently weighed in on TRUP shares. Piper Sandler upgraded shares of Trupanion from a “neutral” rating to an “overweight” rating and set a $57.00 price objective on the stock in a report on Thursday. Northland Securities lifted their price target on Trupanion from $45.00 to $50.00 and gave the stock a “market perform” rating in a report on Thursday, October 31st. Finally, Stifel Nicolaus increased their price objective on Trupanion from $42.00 to $44.00 and gave the company a “hold” rating in a report on Monday, January 6th. Two equities research analysts have rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $45.33.
Read Our Latest Research Report on TRUP
Insiders Place Their Bets
In related news, CFO Fawwad Qureshi sold 622 shares of the firm’s stock in a transaction dated Tuesday, November 26th. The stock was sold at an average price of $52.61, for a total transaction of $32,723.42. Following the transaction, the chief financial officer now owns 9,867 shares of the company’s stock, valued at $519,102.87. This trade represents a 5.93 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, Director Murray B. Low sold 2,000 shares of the company’s stock in a transaction that occurred on Wednesday, November 6th. The shares were sold at an average price of $52.67, for a total value of $105,340.00. Following the sale, the director now directly owns 131,513 shares of the company’s stock, valued at approximately $6,926,789.71. This represents a 1.50 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 28,597 shares of company stock valued at $1,522,082. Insiders own 5.50% of the company’s stock.
Trupanion Profile
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
Recommended Stories
- Five stocks we like better than Trupanion
- What is diluted earnings per share (Diluted EPS)?
- Bloom Energy: Powering the Future With Decentralized Energy
- 3 Tickers Leading a Meme Stock Revival
- Dividend Powerhouses: Blue-Chip Stocks Built for the Long Haul
- How to Calculate Stock Profit
- Why Traders Are Buying the Dip on Johnson & Johnson Stock
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.